About this item:

25 Views | 7 Downloads

Author Notes:

Francisco J. Pasquel, MD, MPH.

Division of Endocrinology, Department of Medicine, Emory University School of Medicine, 69 Jesse Hill Jr Dr. SE, Atlanta, GA 30303.

fpasque@emory.edu.

Drs. Migdal, Jagannathan, Pasquel, and Miller had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Migdal, Qayed, Pasquel, Miller.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Migdal, Pasquel, Miller.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Jagannathan, Qayed.

Administrative, technical, or material support: Migdal, Qayed, Pasquel, Miller.

Supervision: Migdal, Qayed, Cusi, Pasquel, Miller.

Dr. Cusi reported receiving research support as a principal investigator for the University of Florida from Cirius Therapeutics, Echosens, Inventiva, Novartis, Novo Nordisk, Poxel, and Zydus Pharmaceuticals and is a consultant for Allergan, Altimmune, Arrowhead Pharmaceuticals Inc, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Coherus BioSciences, Eli Lilly and Company, Fractyl Laboratories Inc, Hanmi Pharmaceutical Co, Genentech, Gilead Sciences Inc, Intercept Pharmaceuticals, Janssen, Pfizer, ProSciento, Madrigal Pharmaceuticals, and Novo Nordisk. Dr Pasquel reported receiving research support for Emory University from Dexcom, Merck, and Insulet and personal fees from Boehringer Ingelheim, AstraZeneca, Eli Lilly and Co, and Merck outside the submitted work. Dr. Miller reported receiving grant funding through Emory University from Gilead Sciences and serves on an advisory board for AbbVie. No other disclosures were reported.

The AARP, National Institute of Diabetes and Digestive and Kidney Diseases, and National Institute of General Medical Sciences had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Subject:

Research Funding:

Dr. Cusi was partially supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grants R01DK120331 and 1U01DK108320. Dr McCoy was partially supported by NIDDK grants K23DK114497, P30DK111024, and R03DK127010 and an AARP Quality Measure Innovation Grant. Dr Pasquel was partially supported by NIDDK grant P30DK111024 and National Institute of General Medical Sciences grant 1K23GM128221.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Medicine, General & Internal
  • General & Internal Medicine
  • RISK-FACTORS
  • STEATOSIS
  • MELLITUS

Association of Obesity, Diabetes, and Alcohol Use With Liver Fibrosis Among US Adults With Hepatitis C Virus Infection

Tools:

Journal Title:

JAMA NETWORK OPEN

Volume:

Volume 5, Number 3

Publisher:

, Pages e2142282-e2142282

Type of Work:

Article | Final Publisher PDF

Copyright information:

2022 Migdal AL et al.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/rdf).
Export to EndNote